日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Variability in eGFR and the Risk of Adverse Kidney Outcomes and All-Cause Mortality: A Retrospective Observational Study Based on National General Practice Dataset

eGFR变异性与不良肾脏结局和全因死亡风险：一项基于国家全科医疗数据集的回顾性观察研究

期刊:Kidney360
影响因子:3
doi:10.34067/KID.0000000988
Sasaki, Takaya; Buizen, Luke; Harris, Katie; Badve, Sunil V; Chalmers, John; Gallagher, Martin; Ha, Jeffrey T; Jardine, Meg J; Ketema, Daniel B; Kotwal, Sradha S; Neuen, Brendon L; Ronksley, Paul E; Wallace, Hannah; Yokoo, Takashi; Woodward, Mark; Jun, Min
发表日期：2026
文献求助 收藏

Assessing patterns of chronic kidney disease care in Australian primary care: a retrospective cohort study of a national general practice dataset

评估澳大利亚初级保健中慢性肾脏病诊疗模式：一项基于全国全科诊所数据集的回顾性队列研究

期刊:The Lancet Regional Health Western Pacific
影响因子:8.1
doi:10.1016/j.lanwpc.2025.101541
Wallace, Hannah; Wick, James; Ketema, Daniel Bekele; Buizen, Luke; Woodward, Mark; Peiris, David; Neuen, Brendon L; Robertson, Charlotte; Nelson, Craig; Chalmers, John; Badve, Sunil V; Kotwal, Sradha S; Ronksley, Paul; Gallagher, Martin; Jun, Min
发表日期：2025
文献求助 收藏

Sodium-Glucose Cotransporter 2 Inhibition and Hospitalizations in Patients with CKD: A Meta-Analysis of Kidney Outcome Trials

钠-葡萄糖协同转运蛋白2抑制剂与慢性肾脏病患者住院率：肾脏结局试验的荟萃分析

期刊:Clinical Journal of the American Society of Nephrology
影响因子:7.1
doi:10.2215/CJN.0000000771
Oshima, Megumi; Buizen, Luke; Jongs, Niels; Levin, Adeera; Chertow, Glenn M; Wheeler, David C; Heerspink, Hiddo J L; Arnott, Clare; Jardine, Meg J; Mahaffey, Kenneth W; Pollock, Carol; Herrington, William G; Perkovic, Vlado; Neuen, Brendon L
发表日期：2025
文献求助 收藏

Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care dataset

澳大利亚初级保健数据集分析：2 型糖尿病患者（伴或不伴慢性肾脏病）中 SGLT2 抑制剂和 GLP1 受体激动剂处方的使用情况

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.16608
Wallace, Hannah; Wick, James; Neuen, Brendon L; Buizen, Luke; Badve, Sunil V; Chalmers, John; de Oliveira Costa, Juliana; Falster, Michael O; Ha, Jeffrey T; Jardine, Meg J; Ketema, Daniel Bekele; Lin, Jialing; Nelson, Craig; Pearson, Sallie-Anne; Peiris, David; Rodgers, Anthony; Sasaki, Takaya; Woodward, Mark; Gallagher, Martin; Kotwal, Sradha S; Ronksley, Paul; Jun, Min
SGLT2
糖尿病
信号转导
代谢
发表日期：2025
文献求助 收藏

Effects of SGLT2 inhibition on insulin use in CKD and type 2 diabetes: insights from the CREDENCE trial

SGLT2抑制剂对慢性肾病和2型糖尿病患者胰岛素利用的影响：来自CREDENCE试验的启示

期刊:Nephrology Dialysis Transplantation
影响因子:5.6
doi:10.1093/ndt/gfaf044
Beal, Bryony; Buizen, Luke; Yeung, Emily K; Heath, Lauren; Houston, Lauren; Cherney, David Z I; Jardine, Meg; Pollock, Carol; Arnott, Clare; Kotwal, Sradha S; Heerspink, Hiddo J L; Perkovic, Vlado; Neuen, Brendon L
SGLT2
代谢
RED
糖尿病
免疫/内分泌
发表日期：2025
文献求助 收藏

Age-Related Risk of Serious Fall Events and Opioid Analgesic Use

与年龄相关的严重跌倒事件风险和阿片类镇痛药使用

期刊:Jama Internal Medicine
影响因子:23.3
doi:10.1001/jamainternmed.2023.8154
Hopkins, Ria E; Bharat, Chrianna; Buizen, Luke; Close, Jacqueline; Ivers, Rebecca; Draper, Brian; Pearson, Sallie-Anne; Degenhardt, Louisa; Gisev, Natasa
发表日期：2024
文献求助 收藏

Five-Year Trajectories of Prescription Opioid Use

处方类阿片药物使用五年轨迹

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2023.28159
Gisev, Natasa; Buizen, Luke; Hopkins, Ria E; Schaffer, Andrea L; Daniels, Benjamin; Bharat, Chrianna; Dobbins, Timothy; Larney, Sarah; Blyth, Fiona; Currow, David C; Wilson, Andrew; Pearson, Sallie-Anne; Degenhardt, Louisa
发表日期：2023
文献求助 收藏

A data-informed approach using individualised dispensing patterns to estimate medicine exposure periods and dose from pharmaceutical claims data

一种基于数据的方法，利用个体化的配药模式，根据药品索赔数据估算药物暴露时间和剂量。

期刊:Pharmacoepidemiology and Drug Safety
影响因子:2.4
doi:10.1002/pds.5567
Bharat, Chrianna; Degenhardt, Louisa; Pearson, Sallie-Anne; Buizen, Luke; Wilson, Andrew; Dobbins, Timothy; Gisev, Natasa
发表日期：2023
文献求助 收藏

Cohort profile: POPPY II - a population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia

队列研究简介：POPPY II——一项基于人群的队列研究，旨在调查澳大利亚新南威尔士州处方类阿片药物的使用模式和结果。

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2022-068310
Gisev, Natasa; Pearson, Sallie-Anne; Dobbins, Timothy; Buizen, Luke; Murphy, Thomas; Wilson, Andrew; Blyth, Fiona; Dunlop, Adrian; Larney, Sarah; Currow, David C; Mattick, Richard P; Degenhardt, Louisa
发表日期：2023
文献求助 收藏

Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study

降低不确定性：铂类耐药/难治性卵巢癌患者早期停止化疗和生存期缩短的预测因素——GCIG症状获益研究

期刊:Oncologist
影响因子:4.2
doi:10.1634/theoncologist.2017-0047
Roncolato, Felicia T; Joly, Florence; O'Connell, Rachel; Lanceley, Anne; Hilpert, Felix; Buizen, Luke; Okamoto, Aikou; Aotani, Eriko; Pignata, Sandro; Donnellan, Paul; Oza, Amit; Avall-Lundqvist, Elisabeth; Berek, Jonathan S; Heitz, Florian; Feeney, Amanda; Berton-Rigaud, Dominique; Stockler, Martin R; King, Madeleine; Friedlander, Michael
肿瘤
肿瘤免疫
卵巢癌
发表日期：2017
文献求助 收藏